Summary
- Current Price
- As of today, FOLD price is $14.49, with unknown change on
- Current Price All-Time High
- FOLD price is currently -42.93% below its historical high of $25.39 set on
- Market Cap
- FOLD current market cap is $5B, up +126.27% over the past 365 days
- PE Ratio
- FOLD PE ratio is unknown
- Revenue
- FOLD current annual revenue is $634.21M, up +20.05% year-over-year
- Next Earnings
- As of today, the next earnings release for FOLD has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Amicus Therapeutics Inc |
| Ticker | NASDAQ: FOLD |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | amicusrx.com |
| Employees | 511 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $14.49 | |
| Price, 1D Change | - | |
| $5B | ||
| - | ||
| - | ||
| 0.58 | ||
| $634M | ||
| Revenue, 1Y Change | +20.05% | |
| -$0.09 | ||
| EPS, 1Y Change | +52.31% |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$0.09 | ||
| EPS Estimate | N/A | $0.07 |
| EPS Est. Change | N/A | +182.59% |
| $634.21M | ||
| Revenue Estimate | N/A | $752.43M |
| Revenue Est. Change | N/A | +18.64% |
| Current Price | $14.49 | |
| Price Target | - | $14.50 |
| Price Tgt. Change | - | +0.07% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $0.24 | -$0.18 | -178.19% | |
| $0.39 | -$0.09 | -122.37% | |
| $0.07 | N/A | +182.59% | |
| $0.82 | N/A | +1,031.63% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $527.02M | $528.30M | +0.24% | |
| $634.00M | $634.21M | +0.03% | |
| $752.43M | N/A | +18.64% | |
| $888.54M | N/A | +40.10% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Date | Value |
|---|---|---|
| Current Price | $14.49 | |
| $10.88 | ||
| SMA 200 vs Price | -24.91% | |
| $14.40 | ||
| SMA 50 vs Price | -0.60% | |
| 0.58 | ||
| $0.02 | ||
| 71.58 | ||
| 1.18% | ||
| 43.69% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $634.21M | ||
| -$0.09 | ||
| $553.82M | ||
| 87.32% | ||
| $34.49M | ||
| 5.44% | ||
| -$27.11M | ||
| -4.27% | ||
| $41.95M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 1.61 | ||
| 2.84 | ||
| 1.88 | ||
| - | ||
| 4 | ||
| 1.30 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 7.17 | ||
| 16.59 | ||
| 112.00 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $274.24M | ||
| $293.54M | ||
| $949.87M | ||
| $676.17M | ||
| $675.63M | ||
| $237.83M | ||
| $442.36M | ||
| $8.74M | ||
| $28.63M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $661.32M | ||
| $519.33M | ||
| $80.39M | ||
| $383.49M | ||
| $7.46M | ||
| $0.00 | ||
| $27.30M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| $33.15M | ||
| -$46.43M | ||
| $610.00K | ||
| $3.30M | ||
| $29.85M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Jefferies | → | |
| Leerink Partners | → | |
| Citigroup | → | |
| Needham | → | |
| Cantor Fitzgerald | → | |
| Citigroup | ||
| JP Morgan | → | |
| Goldman Sachs | → | |
| Needham | → | |
| Morgan Stanley | → |
Analyst sentiment
Institutional ownership
Screeners with FOLD
FAQ
What is the ticker symbol for Amicus Therapeutics Inc?
The ticker symbol for Amicus Therapeutics Inc is NASDAQ:FOLD
Does Amicus Therapeutics Inc pay dividends?
No, Amicus Therapeutics Inc does not pay dividends
What sector is Amicus Therapeutics Inc in?
Amicus Therapeutics Inc is in the Healthcare sector
What industry is Amicus Therapeutics Inc in?
Amicus Therapeutics Inc is in the Biotechnology industry
What country is Amicus Therapeutics Inc based in?
Amicus Therapeutics Inc is headquartered in United States
When did Amicus Therapeutics Inc go public?
Amicus Therapeutics Inc initial public offering (IPO) was on May 31, 2007
Is Amicus Therapeutics Inc in the S&P 500?
No, Amicus Therapeutics Inc is not included in the S&P 500 index
Is Amicus Therapeutics Inc in the NASDAQ 100?
No, Amicus Therapeutics Inc is not included in the NASDAQ 100 index
Is Amicus Therapeutics Inc in the Dow Jones?
No, Amicus Therapeutics Inc is not included in the Dow Jones index
When was Amicus Therapeutics Inc last earnings report?
Amicus Therapeutics Inc's most recent earnings report was on May 4, 2026
When does Amicus Therapeutics Inc report earnings?
The date for Amicus Therapeutics Inc's next earnings report has not been announced yet
Data Sources & References
- FOLD Official Website amicusrx.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1178879/000117887926000005/0001178879-26-000005-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1178879/000117887926000005/0001178879-26-000005-index.htm
- FOLD Profile on Yahoo Finance finance.yahoo.com/quote/FOLD
- FOLD Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/fold